Dopamine Transporter Imaging has no Impact on Functional Outcomes in de Novo Probable Parkinson's Disease.

about

Dopamine Transporter Imaging has no Impact on Functional Outcomes in de Novo Probable Parkinson's Disease.

Item

http://www.wikidata.org/entity/Q47916161

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Dopamine Transporter Imaging h ...... Probable Parkinson's Disease.

@en

Dopamine Transporter Imaging h ...... Probable Parkinson's Disease.

@nl

type

Item

label

Dopamine Transporter Imaging h ...... Probable Parkinson's Disease.

@en

Dopamine Transporter Imaging h ...... Probable Parkinson's Disease.

@nl

prefLabel

Dopamine Transporter Imaging h ...... Probable Parkinson's Disease.

@en

Dopamine Transporter Imaging h ...... Probable Parkinson's Disease.

@nl

P1476

Dopamine Transporter Imaging h ...... Probable Parkinson's Disease.

@en

P2093

Burton Scott

http://www.w3.org/2001/XMLSchema#string

Lisa Gauger

http://www.w3.org/2001/XMLSchema#string

Maragatha Kuchibhatla

http://www.w3.org/2001/XMLSchema#string

Mark A Stacy

http://www.w3.org/2001/XMLSchema#string

Patrick T Hickey

http://www.w3.org/2001/XMLSchema#string

P2860

A meta-analysis of the association between adherence to drug therapy and mortality

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

Parkinsonism: onset, progression and mortality

Epidemiology of Parkinson's disease

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.

Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.

Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.

Overt versus covert treatment for pain, anxiety, and Parkinson's disease.

P304

279-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JPD-160937

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28339403

http://www.w3.org/2001/XMLSchema#string